223 related articles for article (PubMed ID: 11092402)
21. Pristimerin induces caspase-dependent apoptosis in MDA-MB-231 cells via direct effects on mitochondria.
Wu CC; Chan ML; Chen WY; Tsai CY; Chang FR; Wu YC
Mol Cancer Ther; 2005 Aug; 4(8):1277-85. PubMed ID: 16093444
[TBL] [Abstract][Full Text] [Related]
22. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells.
Mandlekar S; Yu R; Tan TH; Kong AN
Cancer Res; 2000 Nov; 60(21):5995-6000. PubMed ID: 11085519
[TBL] [Abstract][Full Text] [Related]
23. Effects of two novel bisphosphonates on bone cells in vitro.
Evans CE; Braidman IP
Bone Miner; 1994 Aug; 26(2):95-107. PubMed ID: 7994190
[TBL] [Abstract][Full Text] [Related]
24. The bisphosphonate zoledronic acid impairs Ras membrane [correction of impairs membrane] localisation and induces cytochrome c release in breast cancer cells.
Senaratne SG; Mansi JL; Colston KW
Br J Cancer; 2002 May; 86(9):1479-86. PubMed ID: 11986784
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer cells release factors that induced apoptosis in human bone marrow stromal cells.
Fromigué O; Kheddoumi N; Lomri A; Marie PJ; Body JJ
J Bone Miner Res; 2001 Sep; 16(9):1600-10. PubMed ID: 11547830
[TBL] [Abstract][Full Text] [Related]
26. In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates.
Aparicio A; Gardner A; Tu Y; Savage A; Berenson J; Lichtenstein A
Leukemia; 1998 Feb; 12(2):220-9. PubMed ID: 9519785
[TBL] [Abstract][Full Text] [Related]
27. Bisphosphonates in breast cancer.
Coleman RE
Ann Oncol; 2005 May; 16(5):687-95. PubMed ID: 15802276
[TBL] [Abstract][Full Text] [Related]
28. Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells.
Oades GM; Senaratne SG; Clarke IA; Kirby RS; Colston KW
J Urol; 2003 Jul; 170(1):246-52. PubMed ID: 12796698
[TBL] [Abstract][Full Text] [Related]
29. Caspase-3 activity and carbonyl cyanide m-chlorophenylhydrazone-induced apoptosis in HL-60.
Mlejnek P
Altern Lab Anim; 2001; 29(3):243-9. PubMed ID: 11387021
[TBL] [Abstract][Full Text] [Related]
30. Bone-Bound Bisphosphonates Inhibit Proliferation of Breast Cancer Cells.
Park YE; Bava U; Lin JM; Cornish J; Naot D; Reid IR
Calcif Tissue Int; 2019 Nov; 105(5):497-505. PubMed ID: 31324954
[TBL] [Abstract][Full Text] [Related]
31. Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells.
Rachner TD; Singh SK; Schoppet M; Benad P; Bornhäuser M; Ellenrieder V; Ebert R; Jakob F; Hofbauer LC
Cancer Lett; 2010 Jan; 287(1):109-16. PubMed ID: 19577359
[TBL] [Abstract][Full Text] [Related]
32. JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation.
MacFarlane M; Cohen GM; Dickens M
Biochem J; 2000 May; 348 Pt 1(Pt 1):93-101. PubMed ID: 10794718
[TBL] [Abstract][Full Text] [Related]
33. The mediating role of caspase-3 protease in the intracellular mechanism of genistein-induced apoptosis in human prostatic carcinoma cell lines, DU145 and LNCaP.
Kumi-Diaka J; Sanderson NA; Hall A
Biol Cell; 2000 Dec; 92(8-9):595-604. PubMed ID: 11374438
[TBL] [Abstract][Full Text] [Related]
34. Optimizing bisphosphonate therapy in patients with breast cancer on endocrine therapy.
Harvey HA
Semin Oncol; 2004 Dec; 31(6 Suppl 12):23-30. PubMed ID: 15719598
[TBL] [Abstract][Full Text] [Related]
35. Antitumor effects of minodronate, a third-generation nitrogen-containing bisphosphonate, in synergy with γδT cells in human glioblastoma in vitro and in vivo.
Nakazawa T; Nakamura M; Matsuda R; Nishimura F; Park YS; Motoyama Y; Hironaka Y; Nakagawa I; Yokota H; Yamada S; Tamura K; Takeshima Y; Omoto K; Tanaka Y; Ouji Y; Yoshikawa M; Tsujimura T; Nakase H
J Neurooncol; 2016 Sep; 129(2):231-41. PubMed ID: 27393349
[TBL] [Abstract][Full Text] [Related]
36. Bisphosphonates decrease telomerase activity and hTERT expression in MCF-7 breast cancer cells.
Dalle Carbonare L; Valenti MT; Azzarello G; Balducci E; Crepaldi G; Realdi G; Vinante O; Giannini S
Mol Cell Endocrinol; 2005 Aug; 240(1-2):23-31. PubMed ID: 15978718
[TBL] [Abstract][Full Text] [Related]
37. 23,24-Dihydrocucurbitacin B induces G2/M cell-cycle arrest and mitochondria-dependent apoptosis in human breast cancer cells (Bcap37).
Yang L; Wu S; Zhang Q; Liu F; Wu P
Cancer Lett; 2007 Oct; 256(2):267-78. PubMed ID: 17681423
[TBL] [Abstract][Full Text] [Related]
38. Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro.
Ziebart T; Pabst A; Klein MO; Kämmerer P; Gauss L; Brüllmann D; Al-Nawas B; Walter C
Clin Oral Investig; 2011 Feb; 15(1):105-11. PubMed ID: 20024592
[TBL] [Abstract][Full Text] [Related]
39. Z-FA-fmk inhibits effector caspases but not initiator caspases 8 and 10, and demonstrates that novel anticancer retinoid-related molecules induce apoptosis via the intrinsic pathway.
Lopez-Hernandez FJ; Ortiz MA; Bayon Y; Piedrafita FJ
Mol Cancer Ther; 2003 Mar; 2(3):255-63. PubMed ID: 12657720
[TBL] [Abstract][Full Text] [Related]
40. Cytostatic and apoptotic effects of bisphosphonates on prostate cancer cells.
Dumon JC; Journé F; Kheddoumi N; Lagneaux L; Body JJ
Eur Urol; 2004 Apr; 45(4):521-8; discussion 528-9. PubMed ID: 15041119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
